| The global Hemodialysis and peritoneal dialysis market growth forecasted to transform from USD 92.0 billion in 2024 to USD 126.2 billion by 2029, driven by a CAGR of 6.5%. This growth is driven by the rising prevalence of chronic kidney disease (CKD), particularly due to aging populations and increasing rates of diabetes and hypertension. Technological advancements, patient preference for home dialysis, and supportive reimbursement policies are key factors boosting market demand. However, complications linked to dialysis procedures and product recalls pose challenges. The market offers significant opportunities in emerging regions like China, India, and Brazil, where healthcare spending is increasing. Key players include Fresenius Medical Care, Baxter International, and DaVita Inc., and recent developments such as acquisitions and partnerships are enhancing market capabilities. North America is expected to maintain the largest market share due to its advanced healthcare infrastructure and growing adoption of home-based dialysis. |
